• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® D DIMER II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® D DIMER II Back to Search Results
Catalog Number 30455
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of discrepant results associated with vidas® d dimer ii (reference 30455).The customer reported a d dimer result of less than 40 ng/ml.The sample was retested three (3) times and tested on a different vidas® system, but the result obtained was less than 40 ng/ml.There was a delay in reporting the results.An internal biomérieux investigation will be initiated.
 
Manufacturer Narrative
A customer in (b)(6) notified biomérieux of discrepant results associated with vidas® d dimer ii (reference 30455).The customer reported a d dimer result of less than 40 ng/ml.The sample was retested three (3) times and tested on a different vidas® system, but the result obtained was less than 40 ng/ml.An internal biomérieux investigation was performed.The analysis of three (3) internal sample charts (two samples with targets at 116 ng/ml and 201 ng/ml and one sample < 45 ng/ml ) on 21 batches vidas ddex ii between lots 171108-0 and 180427-1 showed that all results are within their specifications.Hypothesis: historical experience related to results below 45 ng/ml, there are different elements: an operator error: if the customer forgets to put the spr in the instrument or the sample in the strip.A pre analytic issue: presence of micro clots of fibrin.Improper maintenance of the instrument.As it is mentioned in the package insert in section limitations of the method: "results below the detection limit of 45 ng/ml obtained with the vidas® d-dimer exclusion ii kit are usually linked to poor pre-analytical or incorrect instrument maintenance and therefore, the assay must be repeated." however in this case, as the result below 45 ng/ml was reproduced on several vidas instruments by different operators and using different vidas d-dimer reagents, and because another sample collected later gave also a low concentration of d-dimer, two (2) additional options were considered: a low concentration of d-dimer for this patient due to clinical history or a treatment.A possible interference leading to an underestimation of the d-dimer including a pre-analytic issue it is mentioned in the package insert, section limitations of the method: "interference may be encountered with certain plasmas containing antibodies directed against reagent components.For this reason, assay results should be interpreted taking into consideration the patient's history (clinical probability)".There is no non-conformity linked to the customer's anomaly for vidas d dimer ii.There were no other complaints of this nature.Conclusion: without any sample available, biomérieux cannot explain the low concentration of d-dimer measured for this specific sample.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® D DIMER II
Type of Device
VIDAS® D DIMER II
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR 
MDR Report Key7014395
MDR Text Key92608614
Report Number3002769706-2017-00355
Device Sequence Number1
Product Code DAP
Combination Product (y/n)N
PMA/PMN Number
K112818
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/01/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number30455
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/05/2017
Initial Date FDA Received11/09/2017
Supplement Dates Manufacturer Received01/05/2018
Supplement Dates FDA Received02/01/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age32 YR
-
-